http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9075001

Outgoing Links

Predicate Object
contentType Clinical Trial|Comparative Study|Controlled Clinical Trial|Journal Article|Research Support, Non-U.S. Gov't
endingPage 23
issn 0315-162X
issueIdentifier 8
pageRange 1418-23
publicationName The Journal of rheumatology
startingPage 1418
bibliographicCitation Hrycaj P, Stratz T, Mennet P, Müller W. Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study. J Rheumatol. 1996 Aug;23(8):1418–23. PMID: 8856622.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_442b1b3662d5ee3c9a51ebb4be2517a4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_820a464fd0a7303f3e0fc17b894d7606
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de8baa72dba608ab1937158f269e34cd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7edea87f2c5b5ba948f85782cb8bfe8e
date 199608
identifier https://pubmed.ncbi.nlm.nih.gov/8856622
isPartOf https://portal.issn.org/resource/ISSN/0315-162X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5243
language English
source https://pubmed.ncbi.nlm.nih.gov/
title Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study
discusses http://id.nlm.nih.gov/mesh/M0026254
http://id.nlm.nih.gov/mesh/M0000115
http://id.nlm.nih.gov/mesh/M0019683
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D017294Q000627
http://id.nlm.nih.gov/mesh/D005356Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D018592
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D012701Q000097
http://id.nlm.nih.gov/mesh/D010147Q000187
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D000082Q000627
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4595
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7740
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983

Total number of triples: 40.